Introduction {#S1}
============

The lysyl oxidase family (LOX; also termed as protein-lysine 6-oxidase) has been traditionally defined as cuproenzymes that are essential for stabilization of extracellular matrix (ECM), particularly cross-linking of collagen and elastin ([@B156]; [@B84]). LOX mainly comprises of five members that were originally considered copper-dependent amine oxidases, including lysyl oxidase and lysyl oxidase-like 1-4 (LOXL1-LOXL4), is a copper-containing amine oxidase belonging to a heterogeneous family of enzymes, which catalyzes oxidative deamination of the amino group in certain lysine and hydroxylysine residues of collagen molecules for stabilization of collagen fibrils ([@B84]). To date, LOX has been demonstrated to regulate a diverse range of cellular processes and biological functions ([@B166]), as well as certain pathogenesis of various diseases, particularly fibrotic diseases, ischemic cardiovascular diseases, and cancer progression, which is mainly mediated by ECM remodeling and elastogenesis ([@B161]), epithelial-mesenchymal transition and intracellular signaling ([@B109]; [@B14]; [@B26], [@B27]; [@B89]; [@B151]; [@B161]). The LOX has been demonstrated as crucial contributors for normal embryonic development of various tissue and organ systems, including cardiovascular ([@B125]), and respiratory systems ([@B120]; [@B119]; [@B121]), as well as essential for normal physiological and cellular properties, such as sprouting angiogenesis of endothelial cells ([@B111]; [@B12]).

Cartilage is an avascular collagen-abundant tissue. Unlike bone, cartilage seems to lack efficient self-reparative/regenerative capacity, making arthritis common and costly, affecting the well-being and quality of life of millions of people worldwide ([@B70]; [@B132]; [@B30]). Inflammatory arthritides, such as rheumatoid arthritis, and psoriatic arthritis, are among the most challenging auto-immune diseases and health problems worldwide ([@B132]; [@B47]; [@B204]). Of note, osteoarthritis (OA) is the most common form of arthritis, which is one of the most prevalent chronic immune diseases. OA is characterized by articular cartilage degeneration, subchondral bone remodeling, osteophyte formation and synovial changes ([@B195]). OA is a multifactorial disease and various risk factors of OA have been reported, such as obesity ([@B8]), body mass ([@B128]), and aging ([@B110]). Until now, the etiology and pathophysiology of OA have not been well documented. Various treatments, such as cellular therapies ([@B49]; [@B95]; [@B102]; [@B175]; [@B191]), administration of certain drugs or chemicals ([@B203], [@B198]; [@B192]), therapeutic surgeries ([@B23]), and bio-fabrication approach ([@B174]; [@B138]; [@B94]), have been intensely studied and tested in various preclinical studies and clinical trials during recent decades ([@B95]; [@B198]). However, several hurdles are required to be addressed for therapeutic optimization before clinical translation. And currently there are no effective clinical options treating OA ([@B132]; [@B24]; [@B55]).

Cross-linking is essential for the stabilization and mechanical support of collagen networks within native cartilage. Of note, the formation of lysine-derived, covalent pyridinoline (PYR) cross-links relies on the enzyme LOX, which is hypoxia-response element-directed upregulation during HIF1-transcriptional activation ([@B182]; [@B51]). The activity of LOX is regulated by proteolytic cleavage of the LOX pro-peptides. Importantly, the activity of LOX is also mainly dependent on the presence of copper ([@B187]). The LOX family plays central roles in the musculoskeletal system, such as tendon ([@B29]; [@B154]; [@B126]), ligaments ([@B123]), and cartilage ([@B74]; [@B123]).

Of note, copper, an important co-factor of various chaperones and enzymes, is vital for maintenance of integrity and homeostasis of cartilage tissues. However, until now, the underlying detailed mechanisms remain elusive. In the current review, we summarized the advances of LOXs family in cartilage homeostasis and regeneration, including embryogenesis, and potential involvement during pathophysiology of arthritis, as well as copper-mediated activation of LOXs and hypoxia-responsive signaling axis during recent decades, the main molecular modulation signaling network controlling LOXs expression, which is promising for potential clinical implications of cartilage regeneration in regenerative medicine and tissue engineering. Also, we propose potential links between the LOXs family and aging-related chronic inflammation and cartilage degeneration. Modulation of certain the LOXs family members may become a promising therapeutic approach for cartilage regeneration.

Lysyl Oxidases in Cartilage Functioning {#S2}
=======================================

Endochondral ossification is one of the two main forms of skeletal formation during embryogenesis. Mesenchymal chondroprogenitor cells differentiate into chondrocytes through cellular condensation processes, which are then surrounded by an abundant layer of extracellular matrix, including type II, IX, and XI collagens, which is the characteristics of cartilage ([@B127]).

Generally, aging-induced cartilage degeneration in arthritis is becoming increasingly prevalent, which is accompanied with the changes in the components of ECM of cartilage ([@B107]; [@B183]). The expression of LO and LOXLs has been detected in chondrocytes near the joint cavity undergoing appositional growth, as well as in the epiphyseal plate of femur undergoing endochondral ossification. Strong expression of LO was observed in marrow cavity. And the localization of LOXL was mainly detected in chondrocytes of the reserve, proliferating cartilage, and hypertrophic zones, suggesting their vital functions during cartilage embryogenesis and potential roles for the normal function of adult cartilage ([@B61]; [@B177]). Further studies have indicated the expression of LO, LOXL2, and LOXL4 on chondrocytes of articular cartilage layers ([@B69]). Also, expression of LOXL2 has been detected in proliferating and hypertrophic chondrocytes of normal growth plate *in vivo* ([@B74]). The general histologic structure of joint cartilage (mainly including growth plate and articular cartilage) has been presented in [Figure 1](#F1){ref-type="fig"}.

![Histology of growth plate and articular cartilage through Safranin O-Fast green staining of the proximal tibia from adult C57BL/6 mice. Mature articular cartilage is mainly comprised of four zones based on histologic features: superficial layer, transition or mid (middle) layer, deep or radial layer, and calcified layer that is lined by subchondral bone. Growth plate is mainly characterized by several morphologically distinct zones, including resting zone, proliferating zone, prehypertrophic zone, and hypertrophic zone. LO is mainly expressed in marrow cavity, while LOXL2 expression is mainly localized in proliferating and hypertrophic zones of growth plate. LOXL was mainly found on chondrocytes of resting, proliferating and hypertrophic zones of growth plate. The expression of LO, LOXL2, and LOXL4 was descended from superficial to deep layers of articular cartilage. Lysyl oxidase: LO; lysyl oxidase like-2: LOXL2; lysyl oxidase like-4: LOXL4; Lysyl oxidase-like enzymes: LOXL. Scale bar: 100 μm.](fbioe-08-00359-g001){#F1}

Notably, the activity of LOX is of pivotal importance for maintaining the tensile and elastic features of connective tissues in the musculoskeletal ([@B189]; [@B64]), cardiovascular and pulmonary systems ([@B135]; [@B133]). In cartilage, LOX is capable of modification of amino acids lysine and hydroxylysine into covalent PYR cross-linking (i.e., heterotypic collagen II/IX/XI) ([@B38]), in particular the most abundant type of cross-links in native articular cartilage, which is tightly correlated with the tensile properties of native articular cartilage ([@B190]; [@B39]). Nevertheless, inactivation of LOXs induced by copper metabolic disorder or gene mutation would lead to dysfunction of connective tissues and collagen-containing organs ([@B91]; [@B120]). To date, the discovery of crystal structures of copper-containing amine oxidase and lysyl oxidase-like 2 has been reported in the current literature ([Figure 2](#F2){ref-type="fig"}) ([@B32], [@B33]; [@B112]; [@B200]).

![Crystal structures and ligand interactions of copper-containing amine oxidase and human lysyl oxidase-like 2 (<http://www.rcsb.org/>). **(A)** Copper- containing amine oxidase extracted from bovine serum (BSAO) was crystallized and its three-dimensional structure at 2.37A resolution. The biological unit of BSAO is a homodimer, formed by two monomers related to each other by a non-crystallographic 2-fold axis. Each monomer is composed of three domains. **(B)** Ligand interaction of copper iron \[(CU)901\] in copper-containing amine oxidase extracted from BSAO. **(C)** Crystal structure of human lysyl oxidase-like 2 (hLOXL2) at 2.4-Å resolution. **(D)** Ligand interaction of zinc iron (\[ZN\]803:A) in hLOXL2. The copper-binding site of hLOXL2 is occupied by zinc, which blocks lysyl tyrosylquinone (LTQ) generation and the enzymatic activity of hLOXL2. The LTQ precursor residues in the structure are distanced by 16.6 Å, corroborating the notion that the present structure may represent a precursor state and that pronounced conformational rearrangements would be required for protein activation.](fbioe-08-00359-g002){#F2}

To date, the LOX family has been reported essential for cartilage maturation, chondroprotection, and homeostasis maintenance of cartilage. LO and LOXL-3b have been demonstrated crucial for cartilage maturation during zebrafish development, respectively ([@B150]; [@B181]). Further, studies have indicated the upregulation of LOXL2 in OA cartilage in response to injury, which may be considered as a naturally protective response that promotes anabolism while inhibiting specific catabolic response during OA pathophysiology ([@B4]; [@B9]). Likewise, a recent study further confirmed that systemic adenovirus-delivered LOXL2 expression or LOXL2 genetic overexpression both exhibited chondroprotective effects through inhibition of catabolic factors and IL-1β-induced NF-κB signaling in mice ([@B173]). Also, Matrigel constructs of human chondrocytes from the knee joint and TMJ implanted in nude mice showed enhanced anabolic responses after LOXL2 transduction, including increased expression of sex determining region Y-box containing gene 9 (SOX9), aggrecan (ACAN), and COL2A1, whilst reduced the levels of extracellular matrix (ECM)-degrading enzymes matrix metalloproteinases and inhibited chondrocyte apoptosis ([@B4]). Therefore, LOX-mediated collagen cross-links are essential for the functional integrity of articular cartilage and cartilage homeostasis. Appropriate modulation of the expression or activity of certain LOXs family members selectively may become potential promising strategy for cartilage repair.

The components of extracellular matrix are vital for the maintenance of phenotype and function of chondrocytes ([@B163]; [@B97]; [@B199]). The expression of a novel LOX-related gene, named LOXC, has been detected in cartilage *in vivo*, which modulates the formation of collagenous extracellular matrix ([@B77]). A series of further studies have confirmed LOX as a key enzyme responsible for the formation of collagen cross-links. Furthermore, hypoxia-induced endogenous LOX expression has been applied in the repair of *de novo* multiple musculoskeletal tissues (i.e., cartilage, meniscus, tendons, and ligaments) as important regenerative strategies, which is mainly mediated through mechanisms of hypoxia-induced enhanced PYR crosslinking and increased tensile properties of collagen-rich tissues ([@B123]).

Simultaneously, studies have demonstrated that combined treatment of copper sulfate and hydroxylysine would additively or synergistically enhance collagen cross-linking in engineered articular cartilage, improving the tensile and biomechanical properties of the neocartilage ([@B122]). LOXL2 promotes chondrogenic differentiation through regulation of SOX9 and SNAIL ([@B74]). Also, LOX activity has been reported vital for phenotypic modulation of chondrocytes ([@B41]). Therefore, modulation of endogenous LOX activity or expression selectively has been demonstrated effective for promotion of tensile properties and cross-linking of cartilage, as well as phenotypic control of chondrocytes, which appears as promising clinically applicable approaches of regenerative medicine and tissue engineering ([@B123]; [@B57]) ([Table 1](#T1){ref-type="table"}).

###### 

Therapeutic approaches for enhanced cartilage regeneration through LOXs modulation.

  **Authors**   **Source/Species**                                        **Detailed Treatments**                                                                                                                                 **Experimental Model**                                                                                       **Therapeutic Outcomes**                                                                                                         **Mechanisms**
  ------------- --------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B123]       Calves                                                    Continuous hypoxia conditioning or exogenous LOXL2 administration                                                                                       Trochlea groove cartilage and knee meniscus explants                                                         Enhanced neocartilage formation and functional properties                                                                        Increased collagen cross-linking
  [@B173]       Mice                                                      Intra-articular injection with MIA (monosodium iodoacetate) or intraperitoneal injection of adenovirus vector (Adv)-RFP-LOXL2                           MIA-induced OA in LOXL2-overexpressing transgenic mice or Cho/+ mice injected with Adv-RFP-LOXL2             Systemic LOXL2 adenovirus or LOXL2 genetic overexpression in mice protected against OA                                           Inhibition of IL-1β-induced phospho-NF-κB/p65 and MMP13 expression; upregulation of anabolic genes
  [@B122]       Juvenile bovine knee joints                               0.0016 mg/ml copper sulfate and 0.146% mg/ml hydroxylysine either or in combination                                                                     Chondrocytes-self-assembly-tissue culture constructs                                                         Synergistic tensile properties in combination of copper sulfate and hydroxylysine-treated group                                  Enhanced PYR cross-links
  [@B57]        Bovine hind limbs taken from skeletally immature calves   Exogenous LOXL2 administration along with copper and free hydroxylysine                                                                                 Culture constructs: primary articular chondrocytes and meniscus cells seeded in non-adherent agarose wells   Enhanced tensile properties of and near-native tissue values in terms of glycosaminoglycan content in LOXL2-treated constructs   Increased collagen and PYR cross-links
  [@B101]       New Zealand white rabbits                                 Copper-incorporated bioactive glass-ceramics (Cu-BGC)                                                                                                   Model of osteochondral defects with a diameter of 5 mm                                                       Facilitated the regeneration of cartilage and osteochondral interface significantly by Cu-BGC treatment                          Activation of HIF-1 signaling and inhibition of inflammatory response via inducing an anti-inflammatory M2 phenotype in macrophage
  [@B4]         Human                                                     *In vivo* implantation of human articular and temporomandibular joints (TMJ) chondrocytes in nude mice; expression detection in human tissue sections   Human knee and hip joints and TMJ                                                                            Upregulated expression of LOXL2 in OA cartilage                                                                                  A protective response that promotes anabolism while inhibition of specific catabolic responses (promoted specific chondrogenesis in implants lacked fibrosis and mineralization)
  [@B74]        Not available                                             Induction of chondrogenic differentiation                                                                                                               ATDC5 cell line                                                                                              Expression of LOXL2 in ATDC5 chondrogenic cells and LOXL2 promoted ATDC5 chondrogenic differentiation                            Through regulation of SOX9 and SNAIL

Regulation of Hypoxia-Inducible Factor-1 in Chondrogenesis and Cartilage Homeostasis {#S2.SS1}
------------------------------------------------------------------------------------

The physiological oxygen tension between 2%∼9% in healthy individuals, which is termed as 'physiologic normoxia' ([@B165]). Generally, hypoxia-inducible factor 1 (HIF-1) is expressed in a variety of organs and tissues in healthy mammalians under physiologic normoxic conditions, including brain, kidney, liver, heart, and cartilage ([@B169]; [@B25]). Articular cartilage is residing in a hypoxic microenvironment of avascular hypoxic zone *in vivo* under normal physiological conditions, ranging from 7∼10% oxygen tensions in the superficial zone, and 1% oxygen in the deep zones ([@B44]). Hypoxia-inducible factor 1α (HIF-1α) have been demonstrated essential for cartilage maturation ([@B35]; [@B168]). Also, local activation of HIF-1α is necessary for survival and homeostatic function of chondrocytes, as well as normal joint development ([@B6]; [@B108]). Thus, hypoxia and HIF-1 have been exploited to modulate chondrocyte phenotype and represent an efficient approach to improve cell properties before implantation for cartilage repair.

Notably, HIF-1 is of pivotal significance for survival and growth arrest of chondrocytes during cartilage development, as well as cartilage homeostasis of osteoarthritic cartilage ([@B142]; [@B52]). HIF-1 is conducive to the maintenance of chondrogenic specific markers (SOX9, type II collagen, and aggrecan) and inhibition of cartilage hypertrophy ([@B34]). HIF-1 has been demonstrated as a positive regulator of SOX9 activity, which is required for chondrogenesis and synthesis of cartilage ECM ([@B153]; [@B197]). Nevertheless, dysregulation of HIF-1α signaling axis would lead to skeletal dysplasia by interfering with cellular bioenergetics and biosynthesis ([@B168]). A recent study has indicated the increased expression of genes involved in matrix degradation, hypoxia-responsive, and inflammatory signaling in damaged cartilages comparing with healthy counterparts through whole genome microarray analysis, suggesting potential involvement of HIF-1α during the progression of OA pathophysiology ([@B196]; [@B7]), which may be a natural protection response of the body since previous studies have demonstrated chondroprotection efficacy through activation of HIF-1 signaling axis ([@B52]; [@B116]; [@B101]). Further comprehensive studies elucidating detailed roles of HIF-1α in certain stages of OA pathogenic progression, as well as detailed mechanisms on hypoxia-induced LOXs expression and activity, require further elucidation. Therefore, appropriate modulation of transcriptional activity of HIF-1α may become a potential feasible therapeutic approach for cartilage regeneration.

Chondroprotective Effects of Copper in Cartilage {#S2.SS2}
------------------------------------------------

Copper, an essential redox-active trace element, which is essential for most aerobic organisms ([@B172]; [@B167]). Simultaneously, copper functions as a co-factor of various proteins and enzymes, including cytochrome C, superoxide dismutase, tyrosinase, ascorbate oxidase, lysyl oxidase, and amine oxidase, exhibiting diverse fundamental cellular functions in normal physiology, including energy generation, iron acquisition, oxygen transportation, cellular metabolism, peptide hormone maturation, blood clotting, neurotransmitter biosynthesis, and intracellular signal transduction ([@B71]; [@B59]; [@B87]; [@B178]; [@B56]; [@B188]; [@B130]). Generally, copper is able to exist in two oxidation states in the body of mammalians: Cu^+^ and Cu^2+^ ([@B100]; [@B145]; [@B167]). The trafficking of copper into specific intracellular targets is delivered by metallochaperones ([@B58]; [@B144]; [@B21]). And there is no free copper in the cytoplasm under normal physiological conditions ([@B147]).

In general, moderate copper levels are essential for normal growth, development, health, such as the normal functioning of innate immune system ([@B31]; [@B13]), and bone health ([@B36]; [@B146]). Of note, copper is also vital for maintenance of integrity and homeostasis of cartilage tissues. Copper metabolic disorder correlates closely with ischemic cardiovascular diseases ([@B82]; [@B88]), embryonic and neonatal abnormalities, and anemia ([@B17]; [@B79]), as well as the onset of osteoarthritis ([@B162]; [@B193]).

Supplementation of dietary copper has been reported to reduce the severity of osteochondrosis and other developmental cartilage lesions, which may result from enhanced collagen cross-linking and increased collagen II synthesis ([@B90]; [@B73]; [@B194]). The chondroprotection efficacy of copper may be attributable to the anti-catabolic effects of Cu^2+^, which abrogates the degradation of cartilage matrix proteoglycan via inhibition of nitric oxide release ([@B139]). A recent study has reported that copper-incorporated bioactive glass-ceramics facilitated the regeneration of cartilage and osteochondral interface effectively, which was mediated in part through activated HIF-1 signaling and inhibited inflammatory response, representing a feasible approach for treating osteoarthritis associated with osteochondral defects ([@B101]). However, until now, the detailed mechanisms of interactions between copper and chondrocytes, as well as copper trafficking within chondrocytes remain elusive. To date, copper has been identified as a cofactor of several identified major cartilage formation-associated enzymes ([@B156]; [@B63]; [@B122]), however, cellular and molecular mechanisms underlying intracellular copper transportation in chondrocytes are not yet clearly understood. A cartilage matrix glycoprotein, a membrane-associated protein synthesized by chondrocytes, has been demonstrated to bind copper and exert some oxidase activity similar with ceruloplasmin, which may function as an important copper transporter in chondrocytes and a potential chondrogenic marker ([@B46], [@B45]; [@B60]; [@B148]; [@B93]; [@B76]; [@B104]; [@B118]). The proposed cellular model of copper intracellular transportation has been presented in [Figure 3](#F3){ref-type="fig"} according to current literature ([@B137]; [@B16]; [@B66]; [@B179]; [@B136]; [@B180]; [@B130]; [@B164]), illustrating the routes of copper trafficking and how it functions within chondrocytes and during ECM remodeling.

![Proposed cellular models of intracellular copper trafficking in chondrocytes. Cu^2+^ is transformed to Cu^+^ by a putative metalloreductase, which then enters the cell through plasma membrane importer CTR1. Once inside the cell, copper is handed off to copper chaperones. CCS incorporated copper into the cytosolic protein Cu/Zn-SOD. ATOX1 delivers copper into secretory compartments of Golgi and Endoplasmic Reticulum through ATP7A/B. Copper can be incorporated into copper-dependent proteins, such as LOXs pro-peptides (secreted forms of LOXs), which is involved in ECM remodeling. Once inside the intermembrane space of mitochondria, copper is handed off to COX17 and then passed onto either SCO1, which then transfers copper to COX2 subunit of cytochrome oxidase, or COX11, which transfers copper to COX1 subunit of cytochrome oxidase. Copper exporter ATP7A/B exports copper out of the cell by translocating to plasma membrane when intracellular copper concentrations are high. Glycoprotein interacts with copper and regulates ECM remodeling. Cu, Copper; Copper-transporter 1, CTR1 (a major copper importer); CCS, Copper chaperone for superoxide dismutase; Cu/Zn-SOD, copper/zinc-superoxide dismutase; ATOX1, a copper chaperone, also known as HAH1; LOXs, lysyl oxidases; COX, cytochrome oxidase; SCO, synthesis of cytochrome c oxidase; ATP, copper transporting P-type ATPases \[systemic copper absorption (ATP7A) and copper excretion (ATP7B)\]; ECM, extracellular matrix.](fbioe-08-00359-g003){#F3}

Further, emerging evidence has indicated that copper stabilizes the HIF-1α protein through inhibiting prolyl hydroxylases-mediated prolyl hydroxylation in an iron-independent manner, which is required for transcriptional activation of HIF-1 of a series of target genes ([@B124]; [@B43]; [@B65]; [@B106]; [@B22]), suggesting that appropriate copper levels may be required for normal cartilage function through regulation of HIF-1α transcriptional activity. However, detailed mechanisms of transcriptional processes initiating specific target genes expression of HIF-1 require further elucidation. Therefore, copper may modulate cartilage homeostasis through regulation of activity of HIF-1 transcription and chondrogenic-associated proteins and markers, such as LOXL2, and SOX9 ([@B153]; [@B5]; [@B160]), as well as VEGF, which is essential for chondrocyte survival ([@B28]; [@B117], [@B116]) ([Figure 4](#F4){ref-type="fig"}). Also, further extensive studies on regulation of HIF-1 expression (such as heat shock protein 90, HSP90), and specific targeting of certain transcriptional activation of certain HIF-1 target genes ([@B131]; [@B75]; [@B85]), as well as regulation of systemic copper metabolism are promising for potential therapeutic optimization ([@B75]; [@B88]).

![Schematic illustration of copper-mediated hypoxia-response element (HRE)-directed transcriptional regulation of cartilage homeostasis-associated genes in chondrocytes. Under normoxia, HIF-1α undergoes PHDs-mediated prolyl hydroxylation, and prolyl OH HIF--1α is ligated by pVHL, an E3 ubiquitin ligase, and degraded by the proteasome finally. Copper stabilizes the HIF-1α protein by inhibiting PHD activity in an iron-independent manner. Under hypoxia or through interaction with HSP90, HIF-1α stabilizes and accumulates in the nucleus where it forms a dimer with the HIF-1β subunit and a putative unidentified copper-chaperone. The dimer then forms a transcriptional complex with coactivator CBP/p300 through binding with HRE, regulating the expression of various downstream target genes, such as LOXL2, SOX9, and VEGF. Simultaneously, the expressions of SOX9-target genes (i.e., Type II collagen, and Aggrecan) are also increased. OH: enzymatic hydroxylation; PHDs, prolyl hydroxylases; pVHL, von Hippel--Lindau tumor suppressor protein; HRE, hypoxia-response element; Ub, ubiquitinated; SOX9, SRY (sex determining region Y)-box 9; HSP90, heat shock protein 90. LOXL2, lysyl oxidase-like 2. VEGF, vascular endothelial growth factor.](fbioe-08-00359-g004){#F4}

Potential Links Between LOX and Aging-Associated Cartilage Degeneration {#S2.SS3}
-----------------------------------------------------------------------

Aging, which is characterized by a chronic and low-grade inflammation, also termed as age-associated inflammation, which has been referred to as 'inflamm-aging' ([@B48]; [@B68]; [@B83]), is also a risk factor of osteoarthritis ([@B54]). Inflammation is a normal process in healthy individuals. Acute inflammation initiates the regenerative response ([@B92]). Whilst chronic inflammation is likely to cause various diseases ([@B3]; [@B105]). The signaling pathways that are implicated in chronic inflammation include NF-κB ([@B155]; [@B10]), signal transducer and activator of transcription (STAT) ([@B62]), mitogen-activated protein kinases (MAPKS) ([@B176]). Interestingly, a recent study reported that LOXL3-mediated deacetylation/deacetylimination abolished the transcription activity of STAT3, thereby inhibiting differentiation of naïve CD4^+^ T cells toward Th17/Treg cells (regulatory T cells) during inflammatory responses ([@B115]).

Aging-associated destruction of joints and cartilage degradation in osteoarthritis is correlated with changes in extracellular matrix of articular cartilage, such as cartilage ECM stiffness, and in the levels and solubility profiles of matrix crosslinks, especially pentosidine, as well as reduced thickness of cartilage, proteolysis, advanced glycation and calcification ([@B37]; [@B143]; [@B110]). Notably, rejuvenation has emerged as a promising therapeutic regenerative approach for improvement or restoration of the self-repair capacity of injured or aging tissue and organ systems ([@B96]; [@B134]; [@B114]; [@B159]), which has been proposed as a conversion into an embryonic-like state recapitulating many events during embryogenesis, including the reactivation of embryonic signature genes, and cytoskeletal/ECM components, and lineage specification ([@B184]; [@B78]; [@B113]; [@B1]; [@B15]; [@B67]; [@B149]; [@B42]; [@B103]; [@B129]). Consistently, the process of cartilage repair has been considered as recapitulation of various events during developmental morphogenesis. Chondrocytes in osteoarthritic articular cartilage usually undergoes a gradual dissolution of anisotropic organization along with re-expression of phenotypic biomarkers of immature cartilage, so tissue maturation is a potential approach for restoration of normal structure and function ([@B18]; [@B86]; [@B72]; [@B81]; [@B201]).

Interestingly, copper is also involved in inflammatory responses, including both innate and adaptive immunity ([@B141]; [@B40]). Increasing evidence has indicated the potential link between copper metabolic disorder and aging-related diseases, such as aging-induced cartilage degradation and dysfunction ([@B193]; [@B110]; [@B171]). And previous studies have demonstrated the vital roles of LOX in normal chondrocyte function ([@B158]; [@B2]), which may be correlated with the pathogenesis of aging-associated osteoarthritis ([@B143]). Moreover, LOXL1 is expressed in major organs in late fetal and neonatal mice, but it generally diminishes in aging animals, which may be associated with aortic fragility resulting from abnormal remodeling of collagen and elastic fibers ([@B61]; [@B11]). The decreased expression of LOXs may attribute to reduction of HIF-1 activity in aging organisms ([@B152]; [@B19]). Meanwhile, LOXL2 has recently been demonstrated as a potential chondroprotective factor in aging related joint osteoarthritis, mainly through inducing anabolic gene expression and attenuating catabolic genes ([@B9]; [@B173]). Thus, restoration of collagen and elastic fiber synthesis in juvenile ECM components though regulation of signaling pathways governing LOX expression may become a promising therapeutic approach for amelioration of aging-associated cartilage degeneration and enhanced cartilage regeneration.

Meanwhile, changes in cell-ECM interactions are important features of aging phenomenon ([@B170]). During the progression of aging-associated degeneration diseases, altered cell fate of adult stem cells, or dysfunction of terminally differentiated mature cells occurs, which may result from the changed ECM niche modified with aging-related proteins and reduced expression of ECM-synthesis-associated proteins ([@B53]; [@B20]; [@B157]; [@B185]; [@B80]; [@B202]; [@B140]), which may be correlated with the LOX family members. Therefore, reverting aging-associated genes in ECM may become an important strategy for joint rejuvenation ([@B20]; [@B50]; [@B98]; [@B170]; [@B186]; [@B205]). Modulation of expression of LOXs family members through transcriptional regulation of HIF-1 may become promising therapeutic approaches for treating aging-induced cartilage degeneration as potential rejuvenating therapies.

Concluding Remarks {#S3}
==================

In summary, LOXs play pivotal roles in maintenance of cartilage function and chondrogenesis. Therapeutic modulation of LOX activity and expression selectively targeting copper-mediated hypoxia-responsive signaling pathways is promising for cartilage repair and OA attenuation. Meanwhile, further extensive basic and preclinical research is warranted for potential translational application of the LOX family in tissue-engineered neocartilage in tissue engineering and regenerative medicine in the future. Specific and moderate manipulation of activities of LOXs and transcriptional regulation of hypoxia-responsive transcription factors through copper bioavailability modulation or continuous hypoxia-conditioning may become effective interventions for enhanced cartilage regeneration, as well as promising rejuvenation therapeutics, which may exert further therapeutic implications in the upcoming clinical arena.

Author Contributions {#S4}
====================

WL and LX made literature review and contributed equally. GL conceptualized the study and critically revised the manuscript. All authors read and approved the final manuscript.

Conflict of Interest {#conf1}
====================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work was partially supported by grants from the National Natural Science Foundation of China (81772322), Hong Kong Government Research Grant Council, General Research Fund (14120118, 14160917, 9054014 N_CityU102/15, C7030-18G, and T13-402/17-N), Hong Kong Innovation Technology Commission Funds (PRP/050/19FX and ITS/448/18), and the Science and Technology Foundation of Guangdong Province (2017A050506046). This study also received support from the SMART program, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong.

[^1]: Edited by: Roberto Narcisi, Erasmus University Rotterdam, Netherlands

[^2]: Reviewed by: Guus van den Akker, Maastricht University, Netherlands; Ryan Michael Porter, University of Arkansas for Medical Sciences, United States

[^3]: ^†^These authors have contributed equally to this work

[^4]: This article was submitted to Preclinical Cell and Gene Therapy, a section of the journal Frontiers in Bioengineering and Biotechnology
